论著-头颈部
NDP联合5-FU诱导化 疗治疗局部晚期鼻 咽癌的疗效及MRI的 临床评估价值
作者:王 炜1 王 虔2
所属单位:1.河南省南阳市中医院影像科 (河南 南阳 473000) 2.南阳医专一附院普外科 (河南 南阳 473000)
PDF摘要
目的 探讨MRI在评估奈达铂 (NDP)联合氟尿嘧啶(5-FU)诱导化疗治疗 局部晚期鼻咽癌中的应用价值。方法 收 集我院2014年5月-2016年5月收治的晚期 鼻咽癌患者60例,所有患者均行奈达铂联 合氟尿嘧啶诱导化疗治疗,于治疗前后进 行MRI检查,计算治疗后总有效率,并比 较复发和纤维化患者MRI曲线斜率。结果 化疗后肿瘤面积较化疗前明显缩小,边界 较前清晰,T1W1低信号、T2W1高信号、 DWI低信号,DCE-MRI扫描呈不均匀强化; CR 31例、PR 24例、SD 2例、PD 3例, 有效率=91.67%;化疗前肿瘤平均面积为 (5.23±3.42)cm2 ;化疗前肿瘤平均面积 为(1.25±1.67)cm2 ,化疗后的肿瘤消退 率=76.11%;随访半年后,复发有13例, 纤维化47例,DCE-MRI扫描显示,复发组 斜率为(19.23±9.27),纤维化组斜率为 (4.53±1.57),纤维化组的斜率明显低于 复发组,差异具有统计学意义(t=10.32, P<0.05)。结论 MRI可以清晰显示肿瘤的 大小、形态、边界,对鼻咽癌患者肿瘤信 号和生物学变化情况具有较高的敏感性, 对化疗后疗效的评估和复发与纤维化组织 的鉴别均具有重要的应用价值。
Objective To explore the application value of MRI in the evaluation of nedaplatin combined with fluorouracil induction chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Methods 60 patients with advanced nasopharyngeal carcinoma admitted in our hospital from May 2014 to May 2016 were selected for the study and treated with nedaplatin combined with fluorouracil induction chemotherapy. MRI examination was performed before and after treatment. The total effective rate after treatment was calculated and the slopes of the MRI curve were compared between the patients with recurrence and fibrosis. Results After chemotherapy, the tumor area was significantly smaller than that before chemotherapy and the boundary was clearer than before. What's more, low signal in T1W1, high signal in T2W1, low signal in DWI and uneven enhancement shown in the DCE-MRI scan were expressed after chemotherapy. There were 31 cases of CR, 24 cases of PR, 2 cases of SD, 3 cases of PD and the effective rate was 91.67%. The average area of tumor was (5.23±3.42)cm2 before chemotherapy and (1.25±1.67)cm2 after chemotherapy, and the tumor regression rate after chemotherapy was 76.11%. After half a year follow-up, there were 13 cases of recurrence and 47 cases of fibrosis. And the slope was (19.23±9.27) in the recurrence group and (4.53±1.57) in the fibrosis group shown by the DCE-MRI scan, and the slope of the fibrosis group was significantly lower than that of the recurrence group, therefore the difference was statistically significant(t=10.32, P<0.05). Conclusion MRI can clearly show the tumor size, shape and border, and has a high sensitivity to the tumor signals and biological changes in patients with nasopharyngeal carcinoma, and has important application values in the efficacy evaluation after chemotherapy and the identification of recurrence and fibrosis tissues.
【关键词】MRI;诱导化疗;晚期鼻咽癌
【中图分类号】R735.2;R445.2
【文献标识码】A
【DOI】 10.3969/j.issn.1672- 5131.2018.04.003
前言
鼻咽癌是头颈部最常见恶性肿瘤之一,早期鼻咽癌患者无明显临 床表现,晚期可表现为鼻塞、头痛、听力下降等非特异性症状,多数 患者就诊时已经处于局部晚期(Ⅲ、Ⅵa期)[1]。98%的鼻咽癌为低分化 鳞癌,由于其恶性程度高,手术难度大,临床常以放化疗为首选治疗 方法[2]。MRI检查在鼻咽癌的临床诊治中具有重要作用,为了进一步证 实MRI在评估晚期鼻咽癌患者接受奈达铂联合氟尿嘧啶诱导化疗后临床 疗效中的价值,本研究回顾性分析了我院60例晚期鼻咽癌患者的临床 资料,现将结果报道如下。
中国CT和MRI杂志
第16卷, 第 4 期
2018年04月
相关文章